Novitium Pharma
Manufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
70 Lake Dr, East Windsor, New Jersey, 08...Phone Number
(855) 204-1431Website
www.novitiumpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Novitium Pharma
Novitium Pharma is a new generic pharmaceutical company that focuses on developing high-quality, affordable medications. With a team of experienced scientists and executives, they manufacture products such as Famotidine and SILDENAFIL, proudly made in the USA. The company serves pharmacists and patients by addressing the demand for accessible prescription options in critical markets. Their commitment to quality and innovation is evident in their state-of-the-art facility and dedication to excellence.Explore more
Novitium Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Novitium Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Novitium Pharma launches new products
Check if Novitium Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Novitium Pharma
Novitium Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Novitium Pharma has new funding data
Earning: See what the market has to say on Novitium Pharma recently announced quarterly report
Click to see if Novitium Pharma had a recent Job posting/layoffs
Check out if Novitium Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Novitium Pharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to Novitium Pharma
Compare insights from companies similar to Novitium Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
-
2008
DW
Daniel WorleyVice President, Business Development & Associate General Counsel
Company Profile Activity
Activity Insights
Novitium Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Novitium Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novitium Pharma.
Novitium Pharma Tech Stack
A closer look at the technologies used by Novitium Pharma
See more technologies
Novitium Pharma News & Media
ANI Pharmaceuticals Completes Acquisition of Novitium Pharma, Significantly Enhancing R&D Capabilities and Scale of Generics and CDMO Businesses
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that it has completed the previously announced acquisition of Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. “Today marks a major milestone for ANI and the many patients who rely on our high-quality, cost-effective medications. With the completion of this acquisition, we bring on board a wANI obtains FTC clearance to acquire Novitium
The acquisition is expected to be completed on or about Nov. 18.Eton to offer generic Carbaglu
Eton will work with Novitium to bring generic Carbaglu to patients later this year.ANI Pharmaceuticals to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding Generics and CDMO Business
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for $163.5 million, including $89.5 million in cash and $74 million in equity plus two potential future cash earn-outs of up to $46.5 million. The transaction has been approved by the ANI
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Novitium Pharma
Sign Up For FreeTo access detailed company insights
Novitium Pharma is a new generic pharmaceutical company that focuses on developing high-quality, affordable medications. With a team of experienced scientists and executives, they manufacture products such as Famotidine and SILDENAFIL, proudly made in the USA. The company serves pharmacists and patients by addressing the demand for accessible presc... Read More
